Michael Klem • Zacks Small Cap Research

Michael Klem is an Equity Research Analyst at Zacks Small Cap Research, specializing in comprehensive analysis of emerging growth companies across the healthcare, technology, and consumer sectors. He covers companies such as NeuroOne Medical Technologies and Xenetic Biosciences, providing detailed company-specific research reports for institutional and retail investors. Klem began his career after earning degrees in Business Administration and Industrial Management from the University of Wyoming and the University of Vermont, and joined Zacks Small Cap Research with a focus on small-cap stocks; prior buy/hold/sell recommendations and coverage history indicate a track record for in-depth diligence but specific performance metrics or third-party analyst rankings are not publicly available. While direct evidence of FINRA registration or securities licenses is not documented in available sources, Klem is recognized for his published equity analyses and professional expertise in small cap research.